Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Galera Therapeutics is a biopharmaceutical company focused on developing small molecule therapies to mitigate side effects of cancer radiotherapy, such as oral mucositis. Its portfolio includes SOD mimetics and a pan-NOS inhibitor targeting aggressive breast cancers like triple-negative and metaplastic subtypes. The company advances clinical-stage candidates, collaborates with research institutions, and relies on third-party manufacturing, aiming to improve cancer treatment outcomes through innovative, targeted therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.